Healthcare

Ramsay Health Care (ASX:RHC) remains one of Australia’s largest private hospital operators, providing healthcare services across Australia, the United Kingdom and Europe.

The company continues expanding its presence in global healthcare markets, supported by long-term software contracts, technology adoption andDemandfor digital healthcare solutions.

For a clinical-stage biotechnology company, moving from shorter dosing periods into longer-term treatment exposure is an important development step. It provides additional insight into durability, tolerability over extended periods and the potential design of future clinical trials.

The New Zealand-based company continues to benefit fromDemandfor respiratory support solutions, with aBusinessmodel supported by both equipment sales and recurring consumable products.

The company now operates a larger pharmacy network while focusing on integration, operational efficiency and international expansion opportunities.

The company operates globally, supplying medical devices and software solutions that support patients and healthcare providers. Its diversifiedBusinessmodel combines hardware products with recurring software-relatedRevenuestreams.

Mayne Pharma reported FY26 revenue of $383.7 million, down 6% on FY25, while grossMarginexpanded 410 basis points to 64.7%. Underlying EBITDA fell 27% to $34.2 million, which the company attributed to disruption from the Cosette transaction process and increased Women's Health sales andMarketinginvestment. Reported …